A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tramadol capsules





Tramadol Capsules - FDA prescribing information, side effects and

8/16/2014
01:27 | Author: Christina Harris

Tramadol capsules
Tramadol Capsules - FDA prescribing information, side effects and

Tramadol Capsules official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more.

Tramadol caused a reduction in neonatal body weight at a dose of 50 mg/kg (1.6-fold the MDHD) and reduced pup survival at an oral dose of 80 mg/kg (approximay 2.6-fold MDHD) when rats were treated during late gestation throughout lactation period.

In vitro drug interaction studies in human liver microsomes indicate that concomitant administration with inhibitors of CYP2D6 such as fluoxetine, paroxetine, and amitriptyline could result in some inhibition of the metabolism of tramadol. Tramadol is metabolized by CYP2D6 to form the active metabolite, O-desmethyl tramadol (M1).

Adverse reactions with incidence rates of 0.5% to <1.0% at any dose and serious adverse reactions reported in at least two patients.

Concomitant use of tramadol increases the seizure risk in patients taking SSRI/SNRI antidepressants or anorectics, TCA antidepressants and other tricyclic compounds, other opioids, MAOIs, neuroleptics or other drugs that lower the seizure threshold [see WARNINGS AND PRECAUTIONS ( 5.1 ) ]

Cardiac disorders: EKG abnormal, hypotension, tachycardia Gastrointestinal disorders: gastroenteritis General disorders: neck rigidity, viral infection Hematologic/Lymphatic disorders; anemia, ecchymoses Metabolism and nutrition disorders: blood urea nitrogen increased, GGT increased, gout, SGPT increased Musculoskeletal disorders: arthritis, arthrosis, joint disorder, leg cramps Nervous system disorders: emotional lability, hyperkinesia, hypertonia, thinking abnormal, twitching, vertigo Respiratory disorders : pneumonia Skin and subcutaneous tissue disorders: hair disorder, skin disorder, urticaria Special Senses : eye disorder, lacrimation disorder Urogenital disorders : cystitis, dysuria, sexual function abnormality, urinary retention.

Tramadol Hydrochloride Extended-Release is available in 150 mg capsules.

The following adverse reactions were reported from all chronic pain studies (N=1917).

Comments (1)Read more



Tramadol extended-release capsules Indications, Side Effects

6/15/2014
03:14 | Author: Devin Garcia

Tramadol capsules
Tramadol extended-release capsules Indications, Side Effects

Easy to read patient leaflet for tramadol extended-release capsules. Includes indications, proper use, special instructions, precautions, and possible side effects.

CSA Schedule 4 Some potential for abuse.

Approval History Calendar Drug history at FDA.

It works in certain areas of the brain and nervous system to decrease pain. Tramadol extended-release capsules is an analgesic.

Availability Rx Prescription only.

When used for long periods of time or at high doses, tramadol extended-release capsules may not work as well and may require higher doses to obtain the same effect as when originally taken. Do not take more than prescribed. This is known as TOLERANCE. Talk with your doctor if tramadol extended-release capsules stops working well.

This information does not endorse any medicine as safe, effective, or approved for treating any patient or health condition.

Comments (2)Read more

Tramadol Hydrochloride 50mg Capsules - Summary of Product

4/14/2014
05:21 | Author: Christina Harris

Tramadol capsules
Tramadol Hydrochloride 50mg Capsules - Summary of Product

Tramadol Hydrochloride 50mg Capsules. Last Updated on eMC 16-Oct-2014 View changes | Actavis UK Ltd Contact details. Patient Information; print SPC this.

Tramadol has a linear pharmacokinetic profile within the therapeutic dosage range. Tramadol passes the blood-brain and placental barriers. Its half-life t1/2,ß (6 healthy volunteers) is 7.9 h (range 5.4 - 9.6 h) and is approximay that of tramadol. There are considerable interindividual quantitative differences between the other metabolites. A serum concentration of 100 - 300 ng/ml is usually effective. 5.3 Preclinical safety data On repeated oral and parenteral administration of tramadol for 6 - 26 weeks in rats and dogs and oral administration for 12 months in dogs, haematological, clinico-chemical and histological investigations showed no evidence of any substance-related changes.

Comments (3)Read more

Tramadol sustained-release capsules

2/13/2014
07:48 | Author: Caitlin White

Tramadol capsules
Tramadol sustained-release capsules

Compared with tramadol SR tablets, tramadol SR capsules produced a smoother plasma concentration profile, with more gradual absorption and lower peak.

Generate a file for use with external citation management software.

Starting treatment with tramadol SR capsules at a dosage of 50 mg twice daily with subsequent dose escalation resulted in improved tolerability in patients with moderate to severe chronic pain. There was less intra- and intersubject variability in tramadol plasma concentrations with SR capsules versus SR. Tramadol SR 100 mg capsules administered twice daily had equivalent efficacy to tramadol IR 50 mg capsules administered four times daily in the treatment of moderate to severe chronic low back pain in a well designed study. The lowest tramadol SR capsule dosage of 50 mg twice daily (administered to 35% of patients with moderate to severe non-oncological pain) significantly improved pain intensity and frequency in 83.4% and 70.4% of patients, respectively, in a postmarketing observational study evaluating tramadol SR capsules 50-200 mg twice daily (n = 3888). A sustained-release (SR) capsule formulation of tramadol gradually releases active drug, allowing for twice-daily dosing. Tramadol SR capsules had identical bioavailability to tramadol immediate-release (IR) capsules with lower peak concentrations and less fluctuation in plasma concentrations. Tramadol is a synthetic, centrally acting analgesic. Compared with tramadol SR tablets, tramadol SR capsules produced a smoother plasma concentration profile, with more gradual absorption and lower peak concentrations. Patients receiving tramadol SR capsules were significantly less likely than those receiving tramadol IR capsules to report nausea.

more. Warning: The NCBI web site requires JavaScript to function.

National Center for Biotechnology Information, U.S. National Library of Medicine 8600 Rockville Pike, Bethesda MD, 20894 USA.

Comments (0)

Tramadol Hydrochloride Extended-release Capsules - RxList

10/22/2014
01:05 | Author: Kate Thompson

Tramadol capsules
Tramadol Hydrochloride Extended-release Capsules - RxList

Find a comprehensive guide to possible side effects when taking ConZip (Tramadol Hydrochloride Extended-release Capsules) for Professionals, Patients, and.

Urogenital disorders: cystitis, dysuria, sexual function abnormality, urinary retention.

l your doctor all medications and supplements you use. ConZip may interact with antidepressants, MAOIs, neuroleptics, quinidine, ketoconazole, antibiotics, lithium, St. During pregnancy, ConZip should be used only if prescribed. John's Wort, triptans, opioids, anesthetic agents, narcotics, phenothiazines, tranquilizers, sedative hypnotics, digoxin, warfarin, carbamazepine, or rifampin. ConZip is an extended-release formulation intended for once a day dosing, starting at an initial dose of 100 mg once daily and adjusted as necessary by 100 mg increments every five days to achieve a balance between relief of pain and tolerability.

Comments (5)Read more